GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Brainscan SA (WAR:BSN) » Definitions » Accumulated Depreciation

Brainscan (WAR:BSN) Accumulated Depreciation : zł0.00 Mil (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Brainscan Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.


Brainscan Accumulated Depreciation Historical Data

The historical data trend for Brainscan's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Brainscan Accumulated Depreciation Chart

Brainscan Annual Data
Trend Dec23 Dec24
Accumulated Depreciation
- -

Brainscan Quarterly Data
Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Accumulated Depreciation Get a 7-Day Free Trial - - - - -

Brainscan Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.


Brainscan Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of Brainscan's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.


Brainscan Business Description

Traded in Other Exchanges
N/A
Address
ul. Kieturakisa 10, Gdansk, POL, 80-742
Brainscan SA is an AI system for lesion detection in the human brain based on computed tomography images. Algorithms powered by artificial intelligence analyze CT brain scans, automatically detecting and highlighting potential pathological changes.